back to overview

news

New MTIP investment in Quanta Dialysis Technologies

June 20, 2018 + Jessica Di Palo
5 Min read

MTIP has invested in Quanta Dialysis Technologies Ltd., a British company that has developed advanced haemodialysis systems for use in clinics and at home.

Quanta haemodialysis solution

MTIP has invested in Quanta Dialysis Technologies Ltd (Quanta), a British company providing innovative haemodialysis solutions for use in clinics and at home.

Renal failure is a huge clinical problem with over two million patients receiving dialysis on a weekly basis. For these patients, treatment consumes great amounts of their time and can be a real burden on their quality of life. Quanta aims to improve these patients’ lives by simplifying and creating more treatment flexibility while maitaining high treatment quality.

“We are delighted to welcome MTIP as an investor and we are grateful for their support at this critical time as we prepare for market launch”, said John E. Milad, CEO of Quanta.

“Quanta has done an amazing job at creating a technology that directly meets the needs of dialysis patient’s. With Quanta‘s SC+ personal haemodialysis, patients will have a simpler and easier treatment whether that be in their local clinic or at home”, said Dr. Christoph Kausch, Founding Partner and CEO of MTIP.

Bruce Meadows, the MTIP’s Senior Investment Director, added that “Quanta is exactly the type of company in our investment sweet spot. It improves patient’s quality of life, it saves them time and it saves money across the healthcare system.”

Share the Article

news

MTIP’s HealthCare Clinic 2022

This year's HealthCare Clinic was held under the motto: "Surfing the Healthtech Waves of Change".

news

Christoph Kausch selected by Real Deals as most influential for 2022

Christoph Kausch named by Real Deals most influential for 2022

news

MTIP leads €17 million financing round in virtual fertility clinic Apricity

New MTIP investment

news

MTIP leads the €20 million growth financing round in LynxCare

Largest capital round ever in digital health in Belgium

blog

Pioneering the use of machine learning algorithms to turbo-charge drug development

Intelligencia revolutionizes drug development

blog

The psychology of decision making

What makes a good investor?

blog

Revolutionizing medical triage with artificial intelligence

Mediktor's solution for medical triage

news

MTIP Closes Second Healthtech Growth Fund Above Target With $250M of Commitments

MTIP Fund II is closed!

blog

Cynerio Now! – A new IoT cybersecurity solution for small hospitals and clinics

Cynerio's new product Cynerio Now!

news

MTIP invests in Mediktor

New investment in Mediktor

blog

SFDR Art. 8 or Art. 9? What’s the difference?

SFDR: getting the terminology right

news

MTIP participates in Oviva’s new $80m Series C funding

Oviva raises $80 million financing round

news

MTIP invests in Intelligencia to reduce the risk of clinical research through artificial intelligence

MTIP's new investment in Intelligencia

blog

Private Equity 101: Part one – Glossary

Are you new to the healthtech space?

blog

Leading brands revolutionize care journeys with Lumeon

How Lumeon orchestrates care journey

blog

Trialbee – our hero in patient matching and recruiting for clinical trials

Trialbee - patient matching and recruiting

news blog

Digital healthcare: patient-first?

Digital Healthcare Report 2021 in collaboration with Dealroom and INKEF Capital

SFDR – How does MTIP approach the EU’s Sustainable Disclosure Regulation?

New SFDR obligations

news

MTIP Announces Strong First Closing of Fund II to drive Healthtech Innovation

First Closing of Fund II

blog

How to pitch to a healthtech Investor

Blog Pitching

news

MTIP invests in Koa Health to make mental health treatment more accessible

New investment in Koa Health

news

MTIP scored fantastic grades in the UNPRI assessment report of 2020

UNPRI Report grades 2020

press

4 Health VCs Share Their Business Priorities and What is Next

Interview Techtour

news

MTIP invests in Trialbee

New investment in Trialbee

news

TytoCare closes $50 million round as the demand for telehealth accelerates

TytoCare closes new round